European Archives - Page 361 of 1178 - European Medical Journal

Contemporary Views on Performance Indicators with Audit-Feedback for Bladder Cancer Treatment

Contemporary Views on Performance Indicators for Bladder Cancer Treatment

Bladder cancers are classified into muscle-invasive and non-muscle-invasive, the latter accounting for 75% of cases.1 Accurate and timely…

Robot-Assisted Distal Ureterectomy Versus Nephroureterectomy in Urothelial Carcinoma

Patients with high-risk upper tract urothelial carcinoma (UTUC) typically undergo radical nephroureterectomy (RNU)…

Defining Urethral Complications of Intermittent Catheterisation Using Hydrophilic Catheters: A Scoping Review

Catheters have been utilised since ancient times to assist individuals incapable of voluntarily emptying their bladder…

Advancements in Prostate Cancer Management

Marcelo Langer Wroclawski, Centro Universitário Faculdade de Medicina do ABC, Santo André, Brazil, opened his talk with an alarming…

Scoring System Predicts Need for Intervention for Non-Muscle Invasive Bladder Cancer Patients

Patients with low-grade (LG) Ta non-muscle invasive bladder cancer (NMIBC) exhibit a high recurrence rate, while cancer-specific…

Twenty-Year Follow-Up of Large-Volume Low-Grade Urothelial Carcinoma

According to the European Association of Urology (EAU) Guidelines, tumour size exceeding 2 cm serves as a crucial factor…

Buccal Mucosa Graft Urethroplasty With or Without Meatus Reconstruction

Approximately 15–20% of patients who undergo urethroplasty (UP) with buccal mucosa graft (BMG) will suffer urethral stricture recurrence…

EAU 2024 Abstract Highlights

PROSTATE-specific membrane antigen (PSMA)-PET imaging can influence decision-making in prostate cancer, improving survival outcomes…

NOTION-2 Trial: Breaking News from EuroPCR 2024

The NOTION-2 trial is a pivotal study that focused on low surgical risk patients aged 75 years or younger, including both tricuspid and bicuspid aortic stenosis (AS) cases…

REC-CAGEFREE II Trial: Breaking News from EuroPCR 2024

Results of the REC-CAGEFREE II trial were presented today at EuroPCR by Ling Tao, FAHA Xijing hospital, Xi’an, China on behalf all REC-CAGEFREE II investigators….